NewGenIvf Group Limited
NIVF
$0.63
$0.034.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 362.50K | 362.50K | -108.20K | -19.90K | -198.30K |
| Total Depreciation and Amortization | -6.10K | -6.10K | 179.90K | 9.30K | 8.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.40K | -1.40K | -175.20K | -10.50K | 4.40K |
| Change in Net Operating Assets | -802.50K | -802.50K | -5.54M | -6.80M | 2.29M |
| Cash from Operations | -447.50K | -447.50K | -5.65M | -6.83M | 2.10M |
| Capital Expenditure | -31.80K | -31.80K | -2.70K | -39.90K | -5.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.74M | -3.74M | 16.40K | -15.30K | -500.00 |
| Cash from Investing | -3.77M | -3.77M | 13.70K | -55.30K | -5.70K |
| Total Debt Issued | 5.01M | 5.01M | 6.17M | -1.02M | 1.97M |
| Total Debt Repaid | -- | -- | 128.30K | -128.30K | -3.20K |
| Issuance of Common Stock | -- | -- | 127.60K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -32.50K | -32.50K | -537.70K | 8.29M | -4.14M |
| Cash from Financing | 4.98M | 4.98M | 5.89M | 7.14M | -2.18M |
| Foreign Exchange rate Adjustments | -187.40K | -187.40K | 32.10K | -271.80K | 142.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 0.00 | 0.00 |
| Net Change in Cash | 575.40K | 575.40K | 288.10K | -14.40K | 65.00K |